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Abstract 
 
Currently, there are no reliable devices for high-throughput drug screening and/or 
testing for anti-angiogenic drugs. Drug testing using 2D cell cultures and animal models 
have been unreliable and lead to high drug failure rates. Three-dimensional cultures hold 
promise in effectively mimicking the in vivo conditions without the high cost of animal 
models. This project was focused on developing a device capable of creating reliable 3D 
microenvironment for use with multiple cell types allowing better cell-cell interactions 
and cellular differentiation. We have developed a 3D cell culture system that can be 
adapted for high throughput analysis in multi-well formats. Our device allows the 
creation of multiple, discrete hydrogel layers containing cells wherein angiogenesis 
initiated as a result of chemotaxis due to the secretion of angiogenic factors by tumor 
cells can be observed, analyzed and quantified. The device is intended to be used as a 
drug testing platform for antiangiogenic drugs as well as for the study of other biological 
phenomena such as cell migration and wound healing.   
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Chapter 1 Introduction 
In 2015, the estimated number of newly diagnosed cancer cases in the United 
States was 1,658,370, with approximately 589,430 deaths (American Cancer Society 
2015). Although there are many anti-cancer drugs approved, and many more in pre-
approval phases, these drugs are very expensive. According to Howard, et al (year), the 
average launch price of anticancer drugs increased at an annual average of approximately 
$8,500 from 1995 to 2013 (Howard, et al. 2015). One in eight women will be diagnosed 
with breast cancer in their lifetime, making it the most highly diagnosed cancer among 
women. Breast cancer is also the second leading cause of death in women, killing over 
40,000 each year in the US alone. Every member of society is at risk for cancer and 
millions are impacted by it each the year.  
The current methods for research and tumor drug testing are inadequate and have 
resulted in far too many failures (American Cancer Society 2015). Drug testing is 
extremely important to ensure that new treatments are safe and effective for consumers. 
Pharmaceutical companies are constantly trying to create advanced and improved 
medications to surpass their competitors. Each year there are new discoveries and 
technologies made that can help improve current medications on the market. Currently, 
there are multiple cell culture methods used in research and drug testing. The methods 
that are used to test newly discovered drugs need to reliably and accurately predict how it 
will function in vivo. One of the major downfall with the current drug testing platforms is 
that only 10% of all assuring preclinical drugs become efficient human treatments (van 
der Worp  et al. 2010). This results in significant financial loss and time by delaying the 
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discovery of new technologies. During 2014, the United States spent about $374 billion 
on drug treatments alone. Additionally, in 2015 global spending on cancer treatments 
reached $100 billion (Leonard 2015). 
Two-dimensional cell culture is a very simple way to culture and observe cells, 
but does not accurately depict in vivo conditions. The cells attach and grow on a hard 
synthetic surface that is not natural to them. Testing the effect of drugs on established cell 
lines grown as monocultures in petri dishes is unreliable and lead to a 95% failure rate in 
drug testing, greatly limiting its application and dependability (Hutchinson and Kirk 
2011).  
Animal testing is another drug testing platform that is commonly used. This 
method is very expensive, requires a lot of time, and has a 92% drug testing failure rate 
(Mak  et al. 2014). Molecular transformation events that occur in human tumors are not 
modeled in the animals (Hutchinson and Kirk 2011). Research on live animals also leads 
to many ethical issues and controversies. 
Three-dimensional cell culture is a much better option to imitate the environment 
of an in vivo system for drug testing. The cells have improved cell-to-cell 
communication, are able to migrate, and can better resemble tissues (Ravi et al. 2015). 
There have been a few techniques created in order to improve the efficiency and accuracy 
of 3D culture methods. Some of these techniques include the hanging drop method, non-
adherent plate, and microfluidic systems (Mehta et al. 2012). Unfortunately, the new 
techniques are often labor and time intensive and require specialized skills to perform. 
Another challenge current 3D cultures face is the lack of ability to create layers that 
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include multiple cell types, in order to observe how they interact with one another (Mehta 
et al. 2012).  
This project involves the design of a device that will be capable of introducing 
cells into a 3D culture in desired concentrations and areas. This will mimic the in vivo 
environment in which a tumor would grow and undergo vasculogenesis. A process that is 
easily scalable will be used to produce layers of cells of consistent size and will 
ultimately allow for accurate drug testing. 
The first step to approach this project is to determine the gel that will be used in 
the device. The gelation time is an important characteristic, because if the gelation time is 
too long the cells will settle to the bottom. The gel being used must also have adequate 
cell attachment. The media used to culture the cells must allow growth for all cell types 
used. The characteristics of the device that will remain the same are the size and 
placement of the different layers that the gels can be made in. One advantage of this 
design is that the specific materials, including the gel, cells, and media can all be 
switched for each experiment run using the device.  
In order for this project to be successful, the team must standardize a process to 
create 3D tumor like structures with multiple cell types. This would ultimately be used 
for anti-cancer drug testing. The device should allow the creation of more reliable and 
accurate multilayer gel system that can incorporate multiple cell types and hence useful 
as a reliable drug testing platform. The team hopes that researchers will be able to use 
this device in order to conduct high throughput drug testing using multiple cell 
type/hydrogel combinations for reliable and consistent results.  
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Chapter 2 Literature Review 
Understanding the workings of tumors and cancer cells is essential for cancer 
related research and tumor drug testing. There are many factors that play part in the 
growth and development of cancerous tumors. In this chapter, the major process that 
keeps tumors alive and growing, angiogenesis, is discussed, along with current 
approaches to study cancer cells, and information on cell lines and biomaterials utilized 
in this project. 
2.1 Angiogenesis 
Tumor angiogenesis is the growth of blood vessels into a tumor from the 
surrounding tissue. This process is induced by angiogenic factors, and halted by anti-
angiogenic factors. Angiogenic and anti-angiogenic factors are essential to the body, as 
blood vessels and stromal components rely on them for processes such as wound healing 
and the development of the placenta during pregnancy. Issues occur when these factors 
are exploited by cancer and tumors (Weis and Cheresh 2011). Tumor angiogenesis is 
induced by the release of angiogenic factors by the tumor mass. There are several factors 
that could contribute to the release of angiogenic proteins, including hypoxia, inactivation 
of tumor suppression genes, or the presence of oncogenes (Folkman 2002).  
Endothelial cells line the blood vessels in a single layer, allowing for equal 
distribution of blood supply and nutrients. Tumor cells differ in that they form multiple 
layers around capillary blood vessels. The multiple layer structure of tumors means that 
some cells are more remote in relation to the blood supply than others. The lack of 
contact with the blood supply results in these remote cells becoming oxygen-deprived, 
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and they enter a state of hypoxia (Folkman 2002). In hypoxia, cancer cells release 
Vascular Endothelial Growth Factor (VEGF), a common angiogenic factor. 
When VEGF comes in contact with its receptor on the surface of endothelial cells 
(VEGFR), a signal is sent to the cell’s nucleus to begin preparations to proliferate and 
grow new vasculature (Nishida et al. 2006). VEGF also induces the production of matrix 
metalloproteinases (MMPs), which break down the extracellular matrix allowing room 
for the recruited endothelial cells to grow in the direction of the tumor (Nishida et al. 
2006). Eventually, these cells form a functioning vascular network to and from the tumor. 
Tumor angiogenesis can also recruit cells from other locations other than preexisting 
vessels, including bone marrow and tumor stem cells (Weis and Cheresh 2011). 
There is large amount of evidence that shows that tumor development is reliant on 
angiogenesis. Without angiogenesis tumors are limited in their size capabilities, typically 
reaching a maximum of only few millimeters in diameter (Weidner et al. 1991). Once 
tumors reach this diameter, hypoxia and necrosis typically follow resulting in cell death 
(Weis and Cheresh 2011). Both tumor growth and metastasis require angiogenesis. 
Metastasis is the migration of cancerous cells from one part of the body to another 
through blood vessels. Hence, an effective platform for the testing of antiangiogenic 
drugs is of paramount importance. An issue with this, as mentioned prior, is that tumors 
have multiple sources for vascular remodeling. Anti-angiogenic drugs may suppress one 
of the modes, but other modes could still be functioning. For a drug to be successful, it 
has to stop a combination of factors. Additionally, an improved drug delivery system is 
essential to target the drug into the tumor environment (Weis and Cheresh 2011). 
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However, testing these drugs in a standardized and reproducible way has been difficult 
because of lack of a reliable method to mimic the in vivo 3D environment. 
 
2.2 Current Approaches  
There are many different techniques and materials employed to achieve in vitro 
and in vivo cultures, each with their own advantages and disadvantages. These techniques 
allow for cell observation, drug testing, and other research using such culturing methods.  
 
2.2.1 Culture Methods 
Two-dimensional (2D) culture is a conventional method involving the growth of 
cells on petri dishes. In this method, cells are grown as monolayers.  While this method is 
inexpensive and allows for basic observation of cells, 2D cultures do not allow cells to 
achieve their native morphology. This method does not accurately depict in vivo 
environments because cells are not normally interacting with synthetic plastics and they 
are generally allowed to grow in multi-dimensions. 2D cell culture is an imprecise 
technique for drug development and testing with a 95% failure rate (Antoni et al. 2015).  
Use of animal models is a reliable method for drug testing. Tumor cells are 
transplanted in the appropriate animal models and drug efficacy is tested once the tumors 
have reached a specific size.  Animal models provide the best morphology when 
compared to 2D cell cultures. They also provide a way to observe systemic effects when 
testing drugs without putting humans in harm’s way. Despite these clear advantages, 
animal models are incredibly expensive. Additionally, the tumor biology in animals and 
humans may differ drastically and hence the effectiveness of the therapy may not be a 
true reflection. This is primarily due to the differences in pharmacokinetics and 
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pharmacodynamics and the differences in the rates and efficiency of drug metabolism in 
animals. Therefore, despite an animal model being considered equivalent to humans, the 
efficacy of drugs can be dramatically different when used in humans resulting in a higher 
drug failure rate in human clinical trials. Considering the aforementioned drawbacks, use 
of 3D gels for initial drug screening may be a good compromise because a good 3D 
system can mimic in vivo conditions better than 2D cell cultures, while at the same time 
minimizing cost of conducting drug tests animal models as a first line of screening the 
drugs. While the 3D system does not eliminate use of animal models altogether, it may be 
able to weed out less active compounds before going to animal testing.  
Three dimensional (3D) cell culture offers a much more realistic environment that 
is closer to in vivo conditions seen in animal models, but at a cost close 2D cultures. This 
technique enhances cell-to-cell communication, migration, proliferation, and response to 
stimuli (Antoni et al. 2015). There are several approaches within the realm of 3D culture 
that are utilized for different applications including hydrogels, scaffolds, microfluidics, 
and spheroids (Mehta et al. 2012). Cells can migrate and proliferate within these 3D 
cultures and behave in a similar manner as their in vivo counterparts. These attributes 
make three-dimensional cell culture the preferred method to conduct cell observation and 
drug development.  
2.2.2 Culture Media  
 
There are many options available to help create 3D culture environment for cells 
and allow for recreation of the in vivo environment. Hydrogels are generally composed of 
linear polymer molecules crosslinked to form a network. These networks are made of 
hydrophilic molecules and can trap large amounts of water within their crosslinks. 
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Gelation is induced by a trigger- such as temperature, pH, introduction of a crosslinker, 
or polymerization (Kasko 2015). Hydrogels can be either synthetic or natural. 
Synthetic hydrogels are widely used because of their adjustability to fit specific 
culture needs. They are easily produced on a large scale and are most often consistent 
among batches (Tibbitt and Anseth 2009). Synthetic hydrogels allow for cells to be 
encapsulated as gelation occurs, and allow for cells to create their own extracellular 
matrix as the hydrogel degrades (Tibbitt and Anseth 2009). Disadvantages of synthetic 
hydrogels include toxic byproducts; as they degrade, some synthetic hydrogels can leave 
behind acidic byproducts, which can interact with cells in the culture causing harm or 
even cell death (Okay 2009). These gels also lack the natural ligands present in the 
extracellular matrix that promote cell attachment and viability. PuraMatrix is a synthetic, 
biocompatible, bioresorbable hydrogel matrix. This product is composed of the repeating 
amino acid sequence Arginine-Alanine-Aspartic Acid-Alanine (1% w/v) and 99% water. 
PuraMatrix self assembles into a hydrogel containing nanoscale fibers in response to 
solutions with salt concentrations greater than 1 mM such as salt containing buffers of 
media. The hydrogels formed are capable of encapsulating cells in three dimensions (BD 
PuraMatrix Peptide Hydrogel 2004). PuraMatrix can be purchased from Corning at a 
volume of 5 ml for about $211 (Corning® PuraMatrix™ Peptide Hydrogel, 5mL 
(Product #354250) 2015).  
Natural hydrogels are beneficial to cell growth because they are derived from 
natural origins. They are extracted from materials and proteins found naturally in the 
extracellular matrix of tissues. Examples include collagen, fibrin, chitosan and alginate 
(Tibbitt and Anseth 2009). Natural hydrogels provide a suitable and familiar habitat for 
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cells in 3D cultures and contain many factors that promote cell attachment, cell viability 
and development. However, their biological sources also present some disadvantages. 
Degradation rate, mechanical properties, and contamination are all concerns when 
working with natural hydrogels. These gels can also have varying properties among 
batches, each affecting cell growth and development in different ways, which is not 
optimal for reproducibility of experiments (Tibbitt and Anseth 2009). Matrigel is natural 
basement membrane matrix derived from Engelbreth-Holm-Swarm (EHS) mouse 
sarcoma cells that can be used as a hydrogel to encapsulate cells in three-dimensions. 
Matrigel is composed of 60% laminin, 30% collagen IV, and 8% entactin. This hydrogel 
has cell attachment properties and polymerizes at 37oC to form a gel. This product can be 
purchased from Corning for about $160.00 for 5 ml (Corning Matrigel Matrix 2013). 
Gelatin is a natural polymer derived from collagen that can be utilized as a hydrogel in 
three-dimensional cultures for its cell attachment properties. This is a much less 
expensive option than Matrigel and can be purchased from Sigma Aldrich for about 
$15.00 for 20 ml (G1393 Sigma Gelatin Solution 2016). Alginate is another natural 
hydrogel that can be used as a matrix in cell culture. This material is reconstituted by 
mixing water or DPBS with powdered Alginic acid, which is isolated from seaweed to 
create a solution of a desired concentration. The alginate solution can be crosslinked 
using Calcium Chloride to form a gel. Alginate does not have natural cell attachment 
properties, however if it is conjugated with RGD peptides it can successfully allow for 
cell attachment. Alginic acid can be purchased from Sigma Aldrich for about $45 for 
100G (A7003 SIGMA Alginic acid from brown algae 2016).  
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2.2.3 Drug Testing and Spheroid Cultivation  
There are a few technologies utilized that help create a 3D culture environment 
for cells and allow them to assemble into spheroids. Spheroids are cross-linked droplets 
of ECM-cell mixtures of varying sizes and can exhibit tumor like characteristics and 
behaviors. The tumor like characteristics include similar nutrient and oxygen gradients, 
cell to cell contact, proliferation rates, and necrosis (Lovitt et al. 2014). Multicellular 
spheroids can be created using multiple techniques including non-adherent surfaces, 
hanging drop, and microfluidics (Mehta et al. 2012).  
 3D spheroid cultures are typically grown either in multi-well plates with a 
hydrophobic, non-degradable coating that has very low cell attachment properties or as 
hanging drops. The cell suspension is transferred on to the non-adherent plate using a 
pipette and the cells form spheroids within the droplets (Corning Incorporated 2014). 
This technique utilizes 96 or 384 well plates; a case of 50 of these plates can be 
purchased from Corning Incorporated for about $1190 (Product #4520 Corning 2015) 
and $1590 (Product #3830 Corning 2015) respectively.  The hanging drop technique is 
expensive and relatively labor intensive and involves a plate with cell suspension hanging 
off the lid. The cell suspension utilizes surface tension to remain on the lid and gravity 
allows the cells to settle and form into a spheroid within the suspension droplet. The plate 
also contains water to create humidity and prevent evaporation of the hanging droplet. 
Microfluidic systems are utilized in spheroid formation by trapping groups of cells into 
chambers (Mehta et al. 2012).  
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2.2.4 Limitations and Adaptations 
Although three-dimensional cell culture is a very reliable technique it has some 
drawbacks and limitations. Some of these include difficult reproducibility, culturing with 
multiple cell types, and the delicate maintenance of conditions like temperature and pH 
within the culture (Antoni et al. 2015). Technologies like the hanging drop and non-
adherent surface plates were developed to combat some of these issues. These methods 
have their advantages and disadvantages and have already been developed further over 
the past few years.  
The traditional hanging drop method can produce spheroids of consistent size and 
involves a relatively simple apparatus. In order to improve the issues with the traditional 
hanging drop technique, a new 384 hanging drop array has been developed. This method 
allows for the creation of 384 spheroids of consistent size, easy manipulation and creation 
of the droplets, and simplified media exchange. An automated system can be utilized to 
pipette 96 wells at the same time at a consistent volume (Tung et al. 2011). The spheroids 
can also be transferred between plates easily once they are formed. Normally hanging 
drop plates are extremely susceptible to damage from agitation, but the 384 well plate 
was developed to stabilize the droplet better by using micro-rings. This allows the culture 
period of the droplets to be extended to over 22 days (Mehta et al. 2012). This improved 
technology for three-dimensional culture allows for a higher production and uniformity 
of spheroids. However, this method has a disadvantage in that spheroids are formed of 
cells alone and is limited by the size of the spheroids wherein cells in the center tend to 
undergo necrosis due to poor nutrient perfusion in large spheroids. Additionally these 
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systems do not allow customization of cellular layers to mimic layers of different cell 
types in a typical tumor. Use of ECM is limited in these systems. 
The use of bioreactors with three-dimensional culture allow for the maintenance 
of ideal conditions to promote cell growth and survival. Bioreactors can control nutrients, 
oxygen, pH, and media flow levels. They also allow for an easily reproducible 
environment between cultures to ensure similar conditions during drug testing or 
research. Some examples of bioreactor technologies utilized in 3D culture are rotating 
wall vessels, spinner flasks, and perfusion systems (Antoni et al. 2015).  
 
2.2.5 Patents 
Intellectual property is an important factor to be aware of during the design phase. 
There are numerous patents that could be beneficial to the creation of a device, but 
innovation must also be involved. Some of the patents that are related to this project 
include cell co-culture systems and processes to standardize the creation of 3D tumor 
spheroids. These patents can be used to see how others have addressed this issue, paying 
attention to both their successes and failures. Many patents have been created in recent 
years for the study of tumor cells. One device patented in 2013 by Kinam Park claims to 
replicate the in vivo environment of 3D tumors and can be used to more effectively 
deliver drugs to tumors. The device is a microfluidic system that can replicate trans-
vascular tumor transport, cellular transmembrane transport, and interstitial transport. 
Another device called the hanging drop, patented in 2011 by Shuichi Takayarma, is a 
method for creating hanging drops of fluids in which you can culture cells. Both of these 
patents along with others must be kept in mind while working on this project. 
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2.3 Cell Lines 
Creating a microenvironment in which to culture and analyze cells first requires 
some knowledge of the cells themselves. Two cell lines were used in this study: the 
breast cancer cell line MDA-MB-231 modified to constitutively express GFP 
(GenTarget, Inc.) and an endothelial cell line, Telomerase immortalized human 
microvascular endothelial cells (TIME cells, ATCC). Characteristics of these cell lines 
are discussed in this section. 
2.3.1 Breast Cancer Cell Line (MDA-MB-231) 
The MDA-MB-231 cell line was first derived from a pleural effusion at a 
metastatic site of a 51-year old Caucasian female (ATCC 2014). It is an epithelial cell 
type and is an adenocarcinoma cell line that originates in the milk ducts of human breast 
tissue (Brinkley et al. 1980). This project used a constitutively expressing Green 
Fluorescent Protein (GFP) variant of this cell line (GenTarget, Inc.) After inducing 
angiogenesis and interacting with other cell types, the cells are able grow large tumors 
and become metastatic in response to cytokine production (Brinkley et al. 1980).  
2.3.2 Endothelial Cell Line (TIME) 
An important angiogenic cell line is Telomerase-Immortalized Human 
Microvascular Endothelial (TIME) cells. The cell line was first derived in 2001 from the 
foreskin of a neonatal male human (ATCC 2014). It has been noted that TIME cells form 
capillary-like tube structures when cultured in the hydrogel Matrigel in conjunction with 
a basal media containing VEGF (ATCC 2014). This study aimed to use tumor cells to 
induce angiogenesis in the TIME cells to form blood vessels.  
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Chapter 3 Project Strategy 
This chapter outlines the objectives and constraints of our project in order to meet 
the client’s needs. The functions and means of the designed device are included in this 
section. It also discusses the intentions and steps necessary to complete the project and 
develop a successful product for the client.  
3.1 Client Statement 
 The initial client statement was presented by the client and advisor, Sakthikumar 
Ambady. 
3.1.1 Initial Client Statement 
The initial client statement was presented as follows, “The aim of this project is to 
develop a device to generate three dimensional biocompatible (spheroid) gels designed to 
grow multiple cell types distributed at specific regions within the gel. The system should 
be optimized for a 3D gel of 100-1000 microns in thickness, preferably in the 250-500 
micron size range. The system should allow easy mixing of cells, fast gelling, easy 
observation, monitoring and analysis under a microscope.” 
3.1.2 Client Needs and Wants  
After providing questions to the client about the initial statement, more detailed 
requirements of the final device were obtained. The client wants a device that can create 
consistent regions for tumor cells to be grown. Cells need to be introduced to this 
environment and suspended in a three dimensional culture in different layers. Tumor cell 
and angiogenic cell lines will be used in the different layers. The client would like this 
culture system to exhibit angiogenic cells forming blood vessels towards the tumor cells. 
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This would then allow researchers to observe whether or not the angiogenesis is inhibited 
during drug testing. Ultimately, this device should allow for more accurate and reliable 
drug testing for anti-tumor drugs by standardizing and facilitating the process of creating 
3D tumor cell cultures. The stakeholder for the final device is Professor Sakthikumar 
Ambady who is the client and advisor of this project. The final device would benefit and 
potentially be utilized by pharmaceutical and research companies during the testing of 
anti-tumor drugs in vitro. The design team for this project included Kailey Castellano, 
Dalton Oakley, Sarah Sisson, and Daniel Youkana. 
3.2 Objective and Constraints  
There are many objectives involved in creating the device outlined by the client. 
This device must be capable of producing standardized PDMS molds used for three 
dimensional cell cultures. The objectives for the design of the device have been outlined 
below. 
3.2.1 Objectives  
There are several primary objectives involved in the design of our device. These 
objectives include that it is efficient, accurate, sterile, and safe. Each of the primary 
objectives is described below and the necessary secondary objectives associated with it 
are listed.  
Sterile: The device needs to produce an uncontaminated environment in order for the 
cultures to be viable. The ranked secondary objectives for sterility are listed below: 
1. Easily sterilized: The device and the molds created need to be easily sterilized 
prior to each application and use.  
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2. Maintains sterility of culture and cells: In order for the results to be accurate, the 
cells need to be sustained in an environment free of contaminants and bacteria.   
Accurate: The device needs to produce accurate regions for the cells to grow. The 
ranked secondary objectives for accuracy are listed below: 
1. Creates layers of consistent volumes: Specifications for the volumes and 
measurements of the device need to be calculated in order to achieve consistently 
sized gel layers for cells to be seeded in. The layers within the cultures need to be 
the same size each time the experiment is conducted.  
Efficient: This device should use a process that is easily scalable and reproducible. This 
will allow for consistent results between culture drug screenings and overall more easily 
obtained and trustworthy results. The secondary objectives for efficiency are listed 
below: 
1. Creation of protocols: Protocols must be established to ensure the device is used 
properly and the cultures are produced consistently. This provides the user with 
clear details on the necessary steps to be conducted during each experiment.  
2. Reproducible: The device needs to create cultures that are easily created 
consistently during each use. The Objet 260 Connex 3D printer at Worcester 
Polytechnic Institute (Stratasys Ltd.) was utilized to create the device to form the 
PDMS channels of consistent sizes for each application.  
3. Scalable: High throughput creation and analysis of the cultures is necessary for 
this device to be successful on the market. The device has been adapted and 
scaled up for use in six-well plates; it can easily be adjusted for 12 and 24 well 
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plates as well. This allows for a multitude of consistent molds to be formed at 
once.  
4. Easy to use: The process associated with the use of the device and analysis of the 
cultures needs to be easy for the user to understand and conduct. The device 
should be adaptable and easily integrated to the current culture plates used in 
laboratories. 
Safe: The device needs to be safe for the user during application. The ranked secondary 
objectives for safety are listed below.   
1. Biocompatible materials for cell growth: It is extremely important that the 
biomaterials used to create the cultures from this device do not inhibit cell 
processes such as differentiation and proliferation. 
2. Safe for user: This device must not pose any health or safety risk to the user.  
3.2.2 Pairwise Comparison Chart  
 
Objectives Safe Sterile Accurate Efficient Total 
Sterile 1 X 1 1 3 
Accurate 1 0 X 1 2 
Efficient 1 0 0 X 1 
Safe X 0 0 0 0 
Table 1: Pairwise Comparison Chart 
 
In order to rank the objectives for this device, a pairwise comparisons chart was 
used to compare and evaluate objectives to one another according to Table 1. The highest 
ranked objective was sterility because if the device is producing contaminated 
microenvironments, the cells will not be able to accurately depict the in vivo 
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environment. This could then lead to false positives on drug screenings and unreliable 
results. The second most important objective was accuracy because the cultures need to 
be produced accurately each time the experiment is conducted or it may not be a scalable 
process in the end. This can also lead to results that are unacceptable and create an 
unreliable process. The third most important objective was efficiency. This is not as 
important as accuracy and sterility because if the device cannot produce an accurate or 
sterile environment there is no reason to scale the process. The lowest ranked objective is 
safety because this device should not pose many health risks to the user, and will also be 
used mainly by trained professionals. Ultimately, this device should be easy to use and 
have minimal danger to users.  
3.2.3 Objectives Tree 
An objective tree was used to visualize and depict the primary objectives and their 
associated secondary objectives outlined in Figure 1 below. 
 
Figure 1: Objectives Tree 
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3.2.4 Constraints 
 
Constraints associated with the design and creations of devices are the limitations 
and restrictions on the design space. Their consideration is extremely important in the 
success of the engineering design process. The constraints have been defined for the 
designed device and outlined below.  
● Manufacturability: The device needs to be designed for relatively simple and 
inexpensive manufacturing for it to be practical in the field.  
● Gelation Time: The gelation time needs to occur relatively quickly so the cells are 
suspended and do not settle to the bottom. This will allow for a three dimensional 
environment to better mimic the in vivo conditions.  
● Culturing of Cells: An ability to culture different cell types is another constraint 
of the culture. Different cell types can interact with one another and are important 
in the creation of an accurate microenvironment. Some cell lines require specific 
media with additives that can have different effects on other cells in the culture. 
This area needs to be researched before deciding on final cell types and can limit 
which cell lines can be used in this project. 
● Culture Time: The amount of time needed between passages of cells and reaching 
an appropriate amount of cells to conduct an experiment is another constraint 
associated with cell culture. It is difficult to determine the growth and survival 
rates of multiple cell types in vitro.  
● Size: The thicknesses of the gels used in the microenvironment are restricted to 
100-1000 microns, but ideally 250-500 microns. This thickness needs to be 
restricted to allow for nutrient perfusion into the culture and to also allow for 
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accurate imaging. If the gel is too thick, the cells will not be able to receive proper 
nutrients to survive and they cannot be imaged clearly. Also, the distance from the 
bottom of the PDMS mold to the formed gel layer within the mold must be below 
4mm to allow for clear imaging.  
There are also constraints associated with the nature of the project in general, which are 
outlined below. 
● Cost: The team is limited to a budget of $624.00. Out of this initial budget, 
$100.00 is deducted for general supplies during use of the laboratories on campus. 
This leaves the team with $524.00 for project costs. Biomaterials like cell lines, 
hydrogels, and media and media supplements are expensive, relative to this 
budget. The budgeted money needed to be used very conservatively on supplies 
that were thoroughly researched to ensure their success in project applications.  
● Time: The total time for the completion of the project is approximately 8 months.  
3.3 Projected Standards 
 
Since this device may be incorporated into pharmaceutical testing trials of anti-
angiogenic drugs it is necessary to address and satisfy industry standards.  
Sterilization: 
Ideally, the device must be sterilizable after manufacturing and after each use. 
The device should be able to withstand autoclaving or chemical sterilization as the case 
may be. 
Cytotoxicity: 
Addressing this issue will be important for the project because the device will 
interact with various cell types. To select materials for use of the device, it should be 
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confirmed that each chosen material does not cause cytotoxicity in any utilized cells. If 
cytotoxicity tests have not been performed on a chosen material or a new material is 
chosen, that material will be tested to determine use.  
 
Devices Containing Human Cells: 
 Despite the many differences that could be found in devices that contain human 
cells, the risks associated with them are all very similar. The device that will be created 
will contain human cells; therefore the risks involved and the proper protocols for 
processing are essential. 
3.4 Revised Client Statement 
 
The initial client statement was altered once the objectives and constraints were 
determined, which is a better representation of the client’s needs and proposed outcomes 
of the project. The revised client statement is as follows, “Design a device capable of 
introducing cells into a 3D culture in desired regions in order to imitate the in vivo 
environment in which a tumor would grow and initiate angiogenesis. This device will 
produce cell regions of a consistent size and allow for accurate drug testing using a 
process that is easily scalable and reproducible.” 
3.5 Project Approach 
 The team hypothesized that this device will create a more accurate 
microenvironment for high throughput drug screening for anti angiogenic drugs aimed at 
cancer treatments.  
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3.5.1 Design of Device  
The overarching goal of the project was to design a device that could produce 
multi-layer hydrogel cultures for 3D cell culture and for observing assays in a 3D 
environment, similar to human tissues. To meet the hypothesis that was previously 
mentioned, the device should be versatile in the sense of hydrogel choices. If the in vivo 
environment of humans was to be mimicked, various hydrogels must be compatible with 
the device material. The design should also allow multiple types of hydrogels to be used 
at once as different layers of the 3D culture. Based on client needs and the hypothesis, the 
device should have high-throughput potential. The device should have the ability to 
produce many cultures simultaneously, or at least produce them rapidly. This would 
increase the reproducibility of assays, and increase the validity of results. 
When the team began the design process, important client needs were considered. 
The most important was the size of the hydrogel layers and the analysis potential. All 
designs that were proposed would restrict the layers to be between 100-1000 microns in 
thickness. Using some method, the team knew that the device had to allow for easy and 
clear imaging to observe cells, or analyze the results of different assays. Any proposed 
designs would have to meet the aforementioned objectives and constraints. Since the 
device would be used with hydrogels and cells, the materials should be biocompatible 
and have no adverse effects on the structural integrity of hydrogels. Following the 
determined objectives, constraints, and other design criteria, the team began the design 
process with various alternatives that will be discussed in a later chapter.  
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3.5.2 Hydrogel Selection 
For device testing, hydrogels that would be used should fit certain criteria. Based 
on the client needs, the hydrogel should exhibit a fast gelling time to prevent cells from 
settling at the bottom of the gels. The gel should maintain a suitable environment for cell 
growth and differentiation. . Following criteria for the device, the gel should allow for 
clear imaging of any assays. It was also important to keep in mind that media and other 
solutions, such as anti-angiogenic drugs, would have to be capable of perfusing through 
the hydrogel layers. Hydrogels that have compositions similar to human tissue were 
considered to be ideal for mimicking the in vivo environment.  
Based on this criteria, the team considered Matrigel, PuraMatrix, alginate, and 
gelatin as possible hydrogel materials . Alginate was considered because it is cheap and 
can gelate quickly using a crosslinker with cations, such as calcium chloride. It could be 
conjugated with RGD-peptide to induce cell attachment properties. Gelatin had slower 
gelation times. Matrigel, though quick to gel is very expensive. Collagen ,is more  
representative of the in vivo environment because collagen is the most abundant ECM in 
human tissues. Finally, PuraMatrix is a synthetic matrix capable of quick gelationin the 
presence of salt at greater than 1 mM concentrations meaning that simple addition of 
culture media to puramatrix can cause immediate gelling. However, the disadvantage is 
that the product is expensive. .  
3.6 Management Approach 
3.6.1 Work Breakdown Structure  
A work breakdown structure was created in order to organize various phases and 
tasks into categories as depicted in Figure 2. It allows the work to be formulated to more 
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manageable tasks. Work breakdown structures create a way to visualize each task that 
needs to be accomplished to achieve the overall project goal.  
 
Figure 2: Work Breakdown Structure 
 
3.6.2 Gantt Chart  
Gantt charts are used to create a timeline of the various phases and deadlines for a 
project. This Gantt chart includes each of the seven weeks in each term of the year. The 
project is broken down into various phases including planning, laboratory, prototyping, 
and project completion. Within each of these phases are multiple tasks that need to be 
accomplished and their projected duration over the term as seen in Figure 3. 
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Figure 3: Gantt Chart 
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Chapter 4 Design Process  
4.1 Needs Analysis  
 
The success of this project was dependent on the design of a device to create 
consistent layers of cell types and hydrogels that would induce angiogenesis. This would 
provide a more accurate and natural microenvironment to study angiogenesis between 
cancer cells and endothelial cells. It would provide a better drug-testing platform for anti-
angiogenic drugs to advance cancer research and treatments.  
The client wants a device that can create consistent microenvironments for tumor 
cells to be grown. Cells need to be introduced to this environment and suspended in a 
three-dimensional culture in different layers and concentrations to more accurately depict 
the in vivo environment than current tumor models. Tumor cell and angiogenic cell lines 
will be used in the different layers. The client would like this culture system to observe 
angiogenic cells forming blood vessels towards the tumor cells. This would then allow 
researchers to test the effect of anti-angiogenic drugs and its ability to inhibit 
angiogenesis during drug testing. Ultimately, this device should allow for high 
throughput, precise, consistent formation of 3D tumor and tissue co-cultures.  
 
4.2 Functions and Specifications  
 
Functions are parameters that describe the goals that a device must accomplish. 
The team decided on a few functions as a baseline to generate design alternatives. The 
first essential function was for the device to easily create hydrogel layers of desired sizes 
consistently. Related to the hydrogel layers, the device should restrict the gel sizes within 
an optimal size range for ease of imaging and analysis.   
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4.2.1 Hydrogel Layers 
 
To meet the client needs, hydrogel layers had to be created within a certain size 
range. The size range is important for microscopic imaging, perfusion, and cell-cell 
interactions in 3-D cell culture. The design of the device should provide a constrained 
region for creating hydrogel layers. This would ensure that the layers are created within 
the size ranges. This function would also allow layers to be repeatedly created of the 
same predetermined size. Being able to create consistent multi-layered hydrogels would 
allow users to conduct many trials of experiments under similar conditions. This would 
allow for more accurate results that are reproducible and can be validated.  
4.3 Feasibility Study/ Experiments 
 
The feasibility of the different aspects of this project had to be examined. The gel 
that would be used for the experiments had to be evaluated for gelation time, cell 
attachment and cell proliferation. . Also, the different designs for the device were 
evaluated for their reproducibility and scalability. Finally, the size of the gel layers was 
tested for feasibility. 
4.3.1 Hydrogels  
 
Numerous different hydrogels were considered for use in the experiments. The 
four hydrogels that were most considered were unmodified alginate, RGD coupled 
alginate, Matrigel, and Puramatrix. The alginate and the RGD coupled alginate were 
tested at both 3% and 6% concentrations. We compared the gelation time of these four 
hydrogels, in order to determine which would allow for the best distribution of cells. 
Additionally, we tested the cell attachment capabilities of all of the hydrogels.  
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4.3.2 Devices 
 
There were three main designs that were built and tested for their feasibility. Each 
of the different designs was evaluated to determine if they could be used to consistently 
produce layers of the desired size. 
4.3.3 Gel Layers 
 
The size of the gel layers was essential to the success of this project. The gel 
layers had to be small enough for the different cells to interact with one another and to 
allow for proper microscopy. The feasibility of the creating gel layers of such small sizes 
was evaluated for each design. 
4.4 Preliminary/ Alternative Designs  
4.4.1 Hanging drop design 
 
The first design that we considered was a modified hanging drop method. In the 
hanging drop method, a drop of liquid is held in place by two sides of an object because 
of surface tension. We laser-cut a sheet of polystyrene into a desired shape with five 
holes, which can be seen in Figure 4. The hydrogel would be pipetted into the center hole 
from the top and it would hang from the bottom because of surface tension. Once gelation 
had occurred, the surrounding holes were used to create a second layer over the first that 
would hang by surface tension. This process is illustrated below in figure 5. It was 
difficult to create a uniform second layer unless all four outer holes were used. However, 
then a third layer couldn’t be created over the first two. Further modifications could be 
made to test the effectiveness of this device. The primary issues with all of the alternative 
designs can be found in section 7.9. 
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Figure 4: Hanging Drop Design (Dimensions in mm) 
 
 
                       
Figure 5: Hanging Drop Process 	
4.4.2 Drill-powered syringe pump design 	
 Another idea was to create three hydrogel layers side-by-side (Figure 6). The 
concept required using pipettes or syringes to create one-hydrogel layer. Then after 
partial gelation, an identical second hydrogel layer would be pipetted adjacent to the first. 
This could be repeated for any number of layers. To optimize this concept for efficiency, 
the team developed a design alternative to produce adjacent layers simultaneously and 
rapidly. Hydrogels could be expelled from multiple syringes simultaneously using a 
syringe pump into crosslinker to cause gelation of multiple layers. Available syringe 
pumps were not capable of flow rates that were fast enough to create uniform layers. 
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Thus, a faster method of expulsion was required. The team developed a drill-powered 
syringe pump to allow for a variety of flow rates. Figure 7 shows the designed syringe 
pump. It has space to hold three syringes. Each was filled with a hydrogel and a small 
amount of dye to observe different colored layers. Small tubing connected the syringes to 
three hypodermic needles that were connected adjacently. A drill is used to push the 
platform down on all three syringes at once. This would expel hydrogel into three 
different adjacent layers into a plate for gelation. Different speeds of the drill created 
different flow rates.  
 
Figure 6: Side-by-side hydrogel layers created from syringe pump 
Layers 1,2, and 3 are created using a syringe pump to expel hydrogels adjacent to one another 
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Figure 7: Syringe pump 
 
 
4.4.3 Negative PDMS mold design 	
 These changes led to a third design alternative to create a channel for multi-
layered hydrogels. It would constrain the layers to a specific size for reproducibility and 
imaging quality. The team designed a negative mold on SolidWorks, as seen in Figure 8. 
The mold was a negative to create a polydimethylsiloxane (PDMS) disc that is 20mm in 
diameter with a small channel to inject the hydrogel layers into. The channel in the disc 
has slots for spacers to be inserted to create the three layers. Using the PDMS disc and 
channel, hydrogel would be injected into the two outer layers (between the center divider 
and each outer divider). After gelation, the dividers could be removed and then the 
middle layer was formed in place of the middle divider. The channel was designed to 
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easily image the hydrogels, allow for nutrient perfusion from media, and allow easy 
analysis of cell-cell interactions and angiogenesis.  
 
Figure 8: Negative mold 
 
4.5 Final Design  
The original negative mold for a PDMS disc reviewed in Section 4.4.3 above with 
a channel was modified to resolve experimental issues. The channel dimensions were 
kept the same. Dimensions that changed are the mold diameter, the inner wall height of 
the mold, and the width and height of the prongs, which create slots for dividers. The 
diameter of the created PDMS disc is 45 mm to prevent damage to the channel when 
removing it from the mold. Prongs act as a negative template to create slots in the 
channel of the disc. These can be used to insert a spacer for creating the layers of 
hydrogel. The team’s final design of a negative mold for a PDMS disc is shown in Figure 
9.  
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Figure 9: Final Negative Mold with Dimensions 
 
To increase the accuracy of the device and create hydrogel layers of consistent 
size, a second component – a divider for the device was created (Figure 10). This 
component is inserted into the slots of the channel in the PDMS disc. The three vertical 
prongs are 13.5mm tall to allow the piece to sit 10 mm above the channel. Hydrogel can 
be injected between the center prong and both outer prongs to create two layers. After 
gelation, the divider component can be removed. Then hydrogel could be injected in 
between the two outer layers to create a smaller center layer. Using the divider 
component, two outer layers of 1mm thick and the center layer of 0.5mm thick could be 
created. These dimensions were chosen for the layers to ensure easy image analysis, 
nutrient/chemical perfusion between the layers, and allows for monitoring the movement 
of cells through the middle layer in response to chemotactic agents. This component 
provides a way to consistently and repeatedly produce three-layer hydrogels for 3D cell 
culture for various assays.  
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Figure 10: Divider Insert for PDMS Mold with Dimensions 
 
One of the team’s objectives was to make the device scalable. Following the 
channel concept within the PDMS disc mold, a device was designed, on SolidWorks, for 
use in a multi-well plate (Figure 11). Using this device, six PDMS discs with channels 
can be created simultaneously. Once the discs are created in the wells of a six well 
culture plate, the discs can be easily removed for experimentation and imaging. Each disc 
could  
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Figure 11: Six-well plate Design 
 
also be left in the plate to conduct multiple assays at once in the same plate. The channel 
dimensions created with this device are identical to the channel dimensions created for 
the single PDMS disc mold described earlier. The rest of the dimensions of this device 
are designed to fit over the wall of the Celltreat 6 Well Tissue Culture Plate similarly to 
how the default lid does (Celltreat Scientific Products, Product Code 229106).  
With proper modifications in the dimensions, this concept could be applied to 
other multi-well plates, such as 12-well 24-well or 48-well plates. By creating a large 
number of 3-D culture channels, a significant number of assays could be performed 
simultaneously to validate results of a desired experiment. 
4.6 Optimization  
 
The dimensions of the three gel layers changed throughout the design process. 
Originally, the size of the gel layers was not a concern; instead creating a device that 
could create gel layers of any size was the focus. Once the design of the device was 
proven, the size of the gel layers that produced the best experimental results was 
determined. The total width of the gel spanning the three layers was determined to be best 
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if it could fit within the field of view of a 5X objective to allow for the entire system to be 
viewed and imaged at one time. This allowed for the three gel layers to be up to about 2.6 
mm wide. The optimal width of the two outside layers was determined to be 1 mm and 
that of the middle layer was determined to be 0.5 mm.  
 Most of the dimensions of the device were determined based on the size of the 
three gel layers. One dimension of the device that was determined independently was the 
thickness of the bottom of the mold that the device would produce. It was determined that 
the total thickness of the device and the gel, including the bottom layer of the mold 
should be no more than 4mm so as to obtain clear images of the cells through the entire 
thickness of the gel.  
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Chapter 5 Design Verification  
5.1 Migration of TIME cells towards the tumor Cells 
 
 Three different gel layers were created using GRGDSP coupled alginate and 
various cell types in conjunction with the device. Alginate-cell suspensions were injected 
into the mold in their respective layers. Layer 1 was seeded with MDA-MB-231-GFP 
cells, layer 2 did not contain cells, and layer 3 was seeded with TIME cells. The layers 
within the mold were crosslinked to form gels using 77 mM calcium chloride. The gel 
layers were imaged and analyzed at days 0, 1, 2, and 3 to observe cell movement and 
potential TIME cell vasculogenesis in response to VEGF across the layers. Images of the 
three separate layers at day 0 are depicted below (Figures 12, 13, and 14) to show the 
presence of cells within their respective layers from the start of the experiment. At day 3, 
the TIME cells were observed in layer 2. Figure 15 images a Hoechst stain for cell nuclei, 
which are present in all three layers. Figure 16 shows the fluorescence imaging at day 3 
which depicts the MDA-MB-231 cells present only in layer 1, from this we can conclude 
that the live cells present in layer 2 are in fact TIME cells that migrated from layer 3.   
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Figure 12. Layer 1, Day 0 containing MDA -MB-231 cells 
Layer 1 is imaged at 10X magnification with the fluorescence filter showing the presence of the GFP 
positive MDA-MB-231 cells at day 0.The distortion of image observed in the image is due to a combination 
of the PDMS base of the device and the thickness of the hydrogel. 
 
 
 
Figure 13: Layer 2 (middle layer), Day 0 
Layer 2 is imaged at 20X magnification to validate that there are no cells present in the layer at day 0.  
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Figure 14: Layer 3, Day 0 containing TIME cells 
Layer 3 imaged at 10X magnification to show TIME cells (see arrows) present within the layer at day 0.  
 
 
  
Figure 15: TIME cell migration from layer 3 towards layer 1. 
Hoechst Stained image showing cell nuclei in the middle layer (see arrows). Culture imaged on Day 3 at 
5X magnification. 
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Figure 16: TIME cell migration Fluorescence of MDA-MB-231 cells 
All three layers imaged on Day 3 at 5X magnification showing Fluorescence of MDA-MB-231 cells present 
in layer 1 only.  
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Chapter 6 Final Design and Validation  
The team developed a device that is capable of satisfying the client’s expectations 
and objectives through the following experimental methods. The methods and efficacy of 
the device can be verified using the outlined analysis methods.  
6.1 Experimental Methods 
6.1.1 RGD-Alginate Conjugation 
 
An adaptation of Carbodiimide chemistry was used in order to covalently attach 
the Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP) peptide (AS-22946, Anaspec) to alginate. 
Alginate is a neutral hydrogel that does not possess ligands for  cell attachment and 
therefore does not support cell attachment, growth and proliferation.  RGD peptides are 
proteins that contain the Arg-Gly-Asp motifs that along with integrins present cell 
attachments sites for cells cultured in RGD conjugated matrices. Stock solutions were 
made for the experiment as outlined in Table 2. This conjugation results in the 
establishment of an amide linkage between the carboxylic acid groups of the alginate and 
the amine terminus of the GRGDSP peptide (Dhoot et al. 2004). See Figure 17 for 
chemical structure of the GRGDSP coupled alginate (Andersen, Auk-Emblem et al. 
2015).  
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Figure 17: Chemical structure of GRGDSP coupled alginate 
 
 
 
Solution Stock Concentrations Final Concentration Volume Used  Source & Cat. # 
Alginate 3% w/v 1% 10 ml Sigma Aldrich, Cat. # 
A1112 
MES  0.5M 0.1M 6 ml Sigma Aldrich, Cat. # 
M3671  
NaCl 3M 0.3M 3 ml Amresco, Cat. #  
7647-14-5  
Sulfo-NHS 100 mg/ml 28 mg/g alginate 84 µl CovaChem, Cat. # 
13505-500 
EDC 100 mg/ml 50 mg/ g alginate 150 µl Sigma Aldrich, Cat. # 
03450 
GRGDSP 5 mg/ml 1 mg/g alginate 60 µl Anaspec, Cat. # AS-
22946  
Table 2: Stock Solutions 
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The conjugation was performed using the following steps: 
 
1. Prepare MES stock solution (0.5M):  
a. Add 9.76g MES buffer powder to about 60 ml of distilled water. 
b. Place on stir plate and stir until dissolved. 
c. Use pH meter and bring pH to 6.5. 
d. Add distilled water to bring total volume to 100 ml. 
e. Use pH meter and bring pH back to 6.5. 
2. Prepare NaCl stock solution (3M): 
a. Add 43.83 g NaCl powder to 150 ml water. 
b. Mix on stir plate until dissolved. 
c. Remove stir bar and add distilled water bring total volume to 250 ml. 
3. Mix 6 ml of MES buffer solution with 3 ml of NaCl solution and add 10 ml of 3% 
w/v alginate. 
4. Add 150 µl EDC stock to solution. 
5. Add 84 µl sulfo-NHS stock to solution (add between 50-200 microliters of NHS 
and EDC to minimize error). 
6. Stir solution for 15 minutes to activate the carboxylic acid groups. 
7. Add 60 µl GRGDSP peptide to the complete solution. 
8. Add distilled water to bring total volume to 30 ml and stir for 24 hours at ambient 
temperature to allow conjugation reaction to occur. 
9. Place solution in dialysis tubing (MWCO 3500 Da) (132112T, Spectrum Labs) 
and clamp both ends. 
10. Place tubing in a 4L autoclaved beaker and gently stir for 3 days. 
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11. Change dialysis water twice in the first 24 hours and then once every 24 hours. 
12. Lyophilize solution to a powder (resulted in 0.16g RGD coupled alginate). 
13. Reconstitute to a concentration of 3% w/v using Ca++/Mg++ free DPBS. 
 
6.1.2 Cell Culture Protocol 
 
The MDA-MB-231-GFP and TIME cells were both cultured using the same 
protocol, but the cells were suspended in different types of media. The MDA-MB-231 
cells were plated with complete media; the components are outlined in Table 3.  
 
Component Stock Solution Volume (mL) Final Percentage 
DMEM basal media 1X 440 88% 
Fetal Bovine Serum (FBS) 100X 50 10% 
Penicillin Streptomycin  5 1% 
GlutaMax  5 1% 
Total Volume  500   
Table 3: Complete Media Components 
 
The TIME cells were cultured with vascular basal media. This media is made 
from vascular cell basal media combined with the endothelial cell growth kit-VEGF 
(PCS100041, ATCC). The growth supplements, seen in Table 4, are added to a 475 mL 
bottle of Vascular Cell Basal Medium. 
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Component Volume (mL) Final Concentration 
Rh VEGF 0.5 mL 5 ng/mL 
Rh EGF 0.5 mL 5 ng/mL 
Rh FGF 0.5 mL 5 ng/mL 
Rh IGF1 0.5 mL 15 ng/mL 
Ascorbic Acid 0.5 mL 50 μg/mL 
L-glutamine 25 mL 10 mM 
Heparin Sulfate 0.5 mL 0.75 Units/mL 
Hydrocortisone 
Hemisuccinate 
0.5 mL 1 μg/mL 
Fetal Bovine Serum 10 mL 2% 
Table 4: VEGF Growth Kit Components 
 
 
The following procedure was used to culture the cell types when they were confluent or 
were being used in experiments: 
1. Aspirate Media 
2. Add 5 ml DPBS (-) (Cat # 21-031-CV, Corning) to rinse cells  
3. Aspirate DPBS (-) 
4. Add 3ml 0.25% Trypsin (Cat # 25-053-Cl, Corning) 
5. Incubate at 37oC for 3 minutes until cells are detached 
6. Add 2 ml of complete media for MDA-MB-231 cells or 2 ml of the vascular 
growth media for the TIME cells to neutralize the Trypsin. 
7. Transfer cell suspension to a 15 ml conical tube 
8. Remove 6 µl of cell suspension a inject in hemocytometer for cell counting 
9. Centrifuge cells at 200G for 5 minutes  
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10. Aspirate media, being careful not to disturb the cell pellet at the bottom of the 
tube. 
11. Resuspend in respective media to achieve density of 1x106 cells/ml. 
12. Re-plate cells on sterile plate to achieve desired density. Add respective media to 
obtain a total volume to 10 ml/plate.  
 
 
6.1.3 3D Printing of Device 
 
 The device consists of two components that were 3D printed. The CAD file 
(SolidWorks 2015) generated for the device was used as the template to print the 
prototype at Worcester Polytechnic Institute by the Department of Mechanical 
Engineering. The device was printed on an Objet 260 Connex printer from Stratsys Ltd. It 
was printed with Objet VeroClear RGD810 plastic.  
 
6.1.4 PDMS Mold Formation 
 
The 3D printed device was used to create the PDMS mold, which contained the 
channels and sections for gel layers to be formed. The procedure is outlined below.  
1. Weigh 10 parts Sylgard Silicone Elastomer base (Ellsworth Adhesive #184 SYL 
ELAST). 
2. Separately weigh 1 part of Sylgard Silicone Elastomer curing agent (Ellsworth 
Adhesive #184 SYL ELAST).  
3. Thoroughly mix the reagents and pour into device, filling to the top of the wall. 
4. Place device in vacuum chamber to degas for at least an hour until all air bubbles 
are eliminated. 
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5. Place in oven at 60 oC to cure for at least an hour until the PDMS is no longer 
tacky.  
6. Remove PDMS from device carefully using forceps. 
 
The resulting mold will contain a channel with spaces for the three layers of gel to 
be injected as depicted in Figure 18.   
 
 
Figure 18: PDMS Mold showing the channels 
 
 
6.1.5 Cell Isolation for Hydrogel Incorporation 
 
The reconstituted RGD-alginate was used to resuspend each of the cell types 
before incorporation into the PDMS layers using the following procedure.  
1. Follow the above outlined cell culture protocol through step 10.  
2. Resuspend the cells in their respective media to achieve a final density of 1x106 
cells/ml.  
3. Remove 0.5 ml of cell suspension (500,000 cells) and place in 1.5 ml 
microcentrifuge tube. 
4. Centrifuge cells at 200G for 5 minutes in the Eppendorf microcentrifuge 
5. Aspirate media being careful not to disturb the pellet at the bottom of the tube. 
6. Resuspend the cells in 100 µl RGD-alginate solution.  
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6.1.6 Hydrogel Injection into Mold 
 
The cell-RGD-alginate mixture is injected into the PDMS mold in their respective 
layers to create the 3D culture using the following protocol. The process is depicted in 
Figure 19 and the final culture is depicted in Figure 20. 
1. Place the divider over the PDMS mold to fit into the slots. 
2. Carefully pipette 10 µL of the MDA-MB-231 and RGD-alginate cell suspension 
into the first layer. Release the gel into the very bottom of the layer slowly to 
avoid air bubble formation. 
3. Place 30 µL of 77mM calcium chloride over the gel layer and allow to crosslink 
for 10 minutes.  
4. Carefully aspirate the calcium chloride from the mold. 
5. Repeat steps 2-4 for the TIME and RGD-alginate cell mixture in layer 3.  
6. Carefully remove the divider without disturbing the two gel layers. 
7. Pipet 10µL of RGD-alginate into the middle layer. 
8. Place 30 µL of 77mM calcium chloride over the newly formed layer and crosslink 
for 10 minutes. 
9. Carefully aspirate the calcium chloride from the mold.  
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1	 2	 3	
MDA-MB-231	cells	 TIME	cells	No	cells	
		
 
Figure 19: Process of Injecting Cell Layers 
Image A depicts the empty PDMS mold. Image B shows the divider placed over the PDMS mold to allow 
for the injection of layers 1 and 3. Image C shows the injection of MDA-MB-231 cells into layer 1 and 
TIME cells into layer 3. Image D shows the divider removed after layers 1 and 3 have been crosslinked and 
the injection of layer 2. 
 
 
 
Figure 20: PDMS mold with formed layers.  
Numbers 1, 2 and 3 denote the three separate layers 
 
 
6.1.7 Media Addition in Channel 
 
Once the hydrogel layers have been formed, the channels on either side of the gel 
layers are filled with the respective media. The channel next to the MDA-MB-231 cells 
was filled with 50 µL of vascular growth media containing VEGF. The channel next to 
the TIME cells was filled with 50 µL regular complete media. This set up allows the 
creation of a gradient of VEGF across the middle layer that exerts a chemotactic force on 
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TIME cells to respond by migrating toward the source of VEGF while at the same time 
differentiating to form vasculature. The culture system is depicted in Figure 21 and was 
used as a proof of principle to induce TIME cell migration and vascularization at a faster 
rate.  
 
Figure 21: 3D culture in PDMS mold with media 
 
6.2 Data Analysis and Validation 
6.2.1 Cell Attachment 
 
The RGD-coupled alginate was compared to regular alginate to assess its cell 
attachment capabilities. Since regular alginate is a neutral gel, it does not possess 
epitopes for cell binding. Cell attachment was observed and analyzed to ensure the RGD-
coupled alginate was capable of encapsulating cells in 3D. Microscopic imaging was 
used to analyze whether the cells were present in different planes of the gel at different 
time points within the gel types.  
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Regular Alginate: 
 
Figure 22: Regular Alginate Cell Attachment 
The bottom, middle, and top layers of the gel were imaged as seen in A, B, and C respectively. PANC-1 
cells were seeded in 3% alginate in a 96 well plate and imaged at various time points. These images depict 
the gels at day 4 at a magnification of 10X. 
 
 
RGD-Alginate: 
 
Figure 23: RGD-Alginate Cell Attachment 
The bottom, middle, and top layers of the gel were imaged as seen in A, B, and C respectively. PANC-1 
cells were seeded in 3% RGD-alginate in a 96 well plate and imaged at various time points. These images 
depict the gels at day 4 at a magnification of 10X. Clumps of cells are present in images B and C.  
 
6.2.2 Hydrogel Layer Formation 
 
The layers formed with the RD-alginate and injected into the mold are imaged 
immediately after crosslinking to ensure the cell types are contained in their respective 
layers at the start of the experiment.  
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Figure 24: Gel Layer Formation- Day 0 
Images of clearly defined and formed layers of cell types. Layer 1 contains MDA-MB-231-GFP cells, layer 
2 does not contain cells, and layer 3 contains TIME cells. The layers are formed with RGD alginate and 
imaged on Day 0, immediately after crosslinking. Image A depicts the layers at 5X magnification with 
arrows pointing to TIME cells and image B depicts the layer 2 at 20X magnification to show no cells 
present.  
 
 
 
Figure 25: Gel Layer Formation with Fluorescence - Day 0 
Imaged with inverted fluorescent microscope (Zeiss) to observe the presence of GFP-positive MDA-MB-
231 cells within layer 1. Images clearly defined and formed layers of cell types. Layer 2 does not contain 
cells and layer 3 contains TIME cells. The layers are formed with RGD alginate and imaged at 5X on Day 
0, immediately after crosslinking.  
 
 
 
 
6.3 Engineering Standards considered in this project 
 
In order for this device to be successfully adopted and incorporated into research 
and drug testing it is necessary that it satisfy the necessary industry standards.  
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1. ISO 11737-2:2009 : Sterilization of Medical Devices 
 
 It is vital that the device is sterilized properly after manufacturing and prior to the 
clients’ first use, since the device will be utilized for drug testing with various cell types. 
This will eliminate the threat of contamination disrupting the cultures leading to 
inaccurate and unreliable results.  
2. ASTM E1766-15: Standard Test Method for Determination of Effectiveness 
of Sterilization Processes for Reusable Medical Devices 
Since the device can be used multiple times to create PDMS molds for different 
cell cultures it is necessary that it be sterilized successfully after each experiment. It is 
also required that the PDMS mold be deemed sterile if it is reused for another 
experiment. Both the device and the PDMS mold can be autoclaved for sterility.  
3. ISO 10993-5:2009 : Cytotoxicity 
 This standard addresses the issue of device biocompatibility with cell types being 
utilized in, or with, the device. Methods are used to check for cytotoxicity whether the 
device comes in direct contact with the cells, or if the diffusion of device extracts could 
cause biological harm. This standard discusses several cytotoxicity tests that can be 
conducted to test potential materials for harmful components. If the test results are 
negative, then the tested material passes the cytotoxicity tests and it can be concluded that 
the material does not harm the cells, and may be biocompatible. This is an important 
standard for this device since it will interact with various cell types and should not cause 
a negative response within the cultures.  
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4. ISO 13022:2012 : Devices Containing Human Cells  
 This standard assesses the risk management and processing requirements for 
medical devices containing human cells. This International Standard details all of the 
hazards that are related to contamination, degradation, and unintended modification of 
such a device. This standard also addresses human material handling, packaging, 
labeling, and much more associated with human cells.  
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Chapter 7 Discussion  
 In this chapter, the design process and results will be discussed in the context of 
the initial client needs and the impact this device could have on society as a whole.  
7.1 Hypothesis Assessment 
 
The hypothesis of this project, as stated in Section 3.5, was as follows, “This 
device will create a more accurate microenvironment for a high throughput drug 
screening for anti-angiogenic drugs aimed at cancer treatments.” The team validated this 
hypothesis through the experimental methods described in Chapter 6. A more accurate 
microenvironment was created by the capability of the device to produce layers, contain a 
variety of gels compatible with cell culture, produce a gradient across the gel layers, and 
allow for interaction of multiple cell types. The microenvironment created can serve as a 
high throughput drug-testing platform because it is created consistently each time and can 
be produced in large quantities using the modified well-plate cover design shown in 
Figure 11. Although angiogenesis was not directly observed over the duration of this 
project, migration of the TIME cells described and imaged in Section 5.1 show that the 
device has potential to create an environment in which angiogenesis can occur. However, 
this project was limited in its duration time, budget, and supplies, hindering the 
successful creation of an angiogenesis assay. Further limitations of this project will be 
discussed later in this chapter. 
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7.2 Objectives Tree Assessment 
 
All of the objectives described in the objectives tree in Figure 1 have been met in 
the final design. This includes the four main objectives in the tree, sterile, accurate, 
efficient, and safe. 
7.2.1 Sterile 
 
The sterility of the device was a major concern throughout the designing phase. 
The device was successfully designed to both be easily sterilized and to maintain the 
sterility of the culture. The device is easily sterilized by autoclaving and allows the user 
to create a new channel for each experiment, if desired. An autoclave is a pressure 
chamber that is used for the sterilization of equipment. The mold can be placed within an 
autoclave for about twenty minutes. The heat and steam within the autoclave sterilizes the 
mold, which upon removal is ready for use. For this project the device was sterilized 
using a different method. After the creation of each PDMS channel, the mold was rinsed 
thoroughly with water and then was allowed to soak for a few minutes in soap and water 
to remove any residual PDMS. The mold was immersed in 70% isopropyl alcohol for 
approximately 5 minutes in a sterilized dish and rinsed thoroughly with sterile DPBS-. 
This method is effective, but autoclaving is suggested if available. The PDMS channel 
created by the mold fits into multiple sizes of culture plates, allowing it to be worked 
with under the hood for sterility. Additionally, if the PDMS channels are to be reused, 
they can also be autoclaved.  
7.2.2 Accurate 
 
The mold allows for the accurate creation of layers of consistent size. The device 
is easy to use and therefore does not allow much room for error while creating the layers. 
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The dimensions of the channels created through our process creates channels that hold 
specific volumes (10 ul for channels 1 and 3 and 5 ul for channel 2) thereby ensuring that 
the channels widths for the two outside layers are consistently 1 mm wide and the middle 
layer is consistently 0.5 mm wide. 
7.2.3 Efficient 
 
The device was designed to be efficient in all aspects. The device is easily 
reproducible. Additionally, the six well plate design, which can be adapted for any sized 
well plate, gives the device scalability. The scaled well plate design allows for the 
creation of up to 96 identical channels at one time. Also, the design of the device is easy 
to use for the user. The creation of the channel is simple. The gel layers can be created 
with relative ease by simple pipetting. Finally, protocols for the conjugation of RGD 
alginate, culturing of the cells, creation of the mold, and injection of the gels have all 
been established. 
7.2.4 Safe 
 
The device maintains the safety of both the user and the cells within it. The device 
does not pose any larger threat to the user, other than the fact that it could possibly 
contain human cells, depending on its use. The mold can be stored in a culture dish, and 
with proper handling it would not place the user in any danger. The safety of the cells is 
ensured because the device materials used, PDMS and RGD alginate, are already known 
to be safe for use in conjunction with cells. 
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7.3 Economic Impact 
 The estimated market value of cancer therapeutics in 2014 was $10 billion, with 
targeted treatments, such as anti-angiogenic drugs, making up approximately 50% of this 
market (Aitken et al. 2015). This is a sizeable market with a lot of potential for simple 
devices such as ours that can make a big difference in diagnostics and patient outcomes. 
We believe that our device can be incorporated into the drug pipeline by pharmaceutical 
companies to improve drug testing during the early phases of drug development. With the 
advent of personalized medicine, our platform may be adapted for testing patient specific 
cells derived from biopsies to test for angiogenic and metastatic properties of the cells, 
paving the way for more targeted therapy for the patients resulting in better outcomes and 
ultimately reduce the overall cost of treatment per patient.  
 
7.4 Environmental Impact 
 
This project does not generate any additional waste that can negatively impact the 
environment. The mold does not have to be disposed of and PDMS is considered to be 
non-hazardous to the environment. One negative environmental impact of the device is 
that it requires the use of typical laboratory equipment, like culture dishes and pipette 
tips, which can generate a lot of plastic waste. One way to improve this would be to use 
more environmentally friendly versions of this equipment, such as reusable or recyclable 
equipment.  
7.5 Societal Influence 
 
This project could have a substantial impact on society. The device should allow 
for the improved study of angiogenesis and for improved anti-angiogenic drug testing. 
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This could help to lower the failure rate of future drugs, which could then improve the 
quality of life of cancer patients. This device could also be used to study numerous other 
diseases, which would then increase its societal impact. 
7.6 Political Ramifications 	 This	device	would	not	have	any	political	ramifications	since	there	are	other	cancer	drugs	currently	being	tested.	It	could	however,	result	in	a	more	effective	cancer	treatment	by	allowing	for	more	reliable	drug	testing.		
7.7 Ethical Concerns 	 Since	this	device	could	result	in	more	effective	cancer	treatments,	it	could	improve	the	quality	of	life	of	cancer	patients.	Also,	it	will	decrease	the	cost	of	treatment,	lessening	the	financial	burden.		
7.8 Health and Safety 
Overall, this device allows for a more accurate microenvironment and drug-
testing platform than the current methods used. This will lead to lower drug failure rates 
when using this device. Since researchers will spend less time testing ineffective drugs, 
they will be able to develop successful therapeutics quicker, which will lead to an 
improvement in health. It will also improve the safety for patients taking the medications 
since the efficacy will be determined in a more reliable manner. There may be a decline 
in the amount of recalls and adverse responses from approved medications.   
7.9 Manufacturability 
 
The manufacturability of the device was considered throughout the designing 
phase of this project. The mold was created on SolidWorks, and these files can be 
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converted and printed using a 3D printer. The well plate design of the device increases its 
scalability, and it can be manufactured to fit any sized plate.   
7.10 Sustainability  	 The	sustainability	of	this	device	is	very	high	due	to	the	fact	that	it	is	reusable	and	made	from	recyclable	materials.	This	will	prevent	excessive	waste	from	the	use	of	this	device.		
7.11 Angiogenesis Detection 
 The next step after observing cell migration is the detection of angiogenesis. 
There are multiple ways of detection. The first method is by visual cues. Tubular 
structures will be formed by the endothelial cells, which should be visible under a 
microscope. Another method of detection is through the use of cell receptors. CD31 is a 
cell receptor that mediates the attachment of endothelial cells in blood vessels. A positive 
stain for this receptor will prove that the tubular formations seen in the assay are indeed 
blood vessels formed from endothelial cells. 
7.12 Alternative Designs 
The alternative designs had several issues that hindered their usefulness. One 
issue with the hanging drop design was the manufacturing of the device. The shape and 
holes were cut out from polystyrene using a laser. Since the holes were only 1mm in 
diameter, the laser was concentrated at single points to make each hole with burned and 
warped the material. These defects made it difficult to pipette a hydrogel drop and keep it 
stabilized. A more heat resistant material that is still hydrophobic enough to hold the 
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hydrogel drops in place would be ideal. To create additional layers that are uniform and 
accurately reproducible, more holes would have to be added outside of the current ones. 
The primary concern with the drill powered syringe pump design was that the 
layers were not contained. Layers were created to be too long or too thick for imaging 
and study of cell-cell interactions. Another issue was that the required faster flow rate 
through the small tubing was not optimal for the cell survival. The team focused on the 
concept of creating adjacent hydrogel layers, but developed a third design alternative to 
create layers of consistent size as well as avoid the fast flow rates of the team’s syringe 
pump.  
Two issues were found when testing the negative PDMS mold design. First, the 
disc was too small in relation to the channel, which made it difficult to remove the disc 
from the mold without damaging the channel. The disc was modified to have a larger 
diameter to prevent damage. Another issue is that dividers were not stable causing 
variation in the gel layers and often made it difficult to create layers at all. The slots for 
the dividers were made larger overall to provide more stability and consistency. This 
alternative has acted as the blueprint for the team’s final design. Various forms of the disc 
were created after making modifications. 
  
7.13 Limitations 	
 Throughout the year there were several limitations that affected the project. The 
three largest limitations were time, budget, and supplies. Experimentation and testing 
were limited since the timeline of the project was constrained to nine months. The team’s 
budget for the entire project was about $550, which was not very accommodating to this 
	 	 		
	 62	
project considering the high expenses of biological supplies. A final example of a 
limitation that affected the project is the growth of the different cell lines. The team was 
not able to conduct experiments as frequently as they would have liked to due to the slow 
growth of the cell lines used, in particular the TIME cells. 
 
7.14 Additional Applications 
 Although the team focused on an angiogenic assay, this device has numerous 
additional applications. This device can be used to study cell migration and cell to cell 
interactions between any cell types and within many types of hydrogels. Cell migration 
has an impact on wound healing, a large majority of diseases, and on transplant rejection. 
One specific application of this device includes research on nerve regeneration in 
response to nerve growth factor.  It is believed that enhanced expression of nerve growth 
factor (NGF) and the low-affinity NGF receptor (LNGFR) may promote Schwann cell 
migration. Increased Schwann cell migration will improve regeneration if damage to a 
nerve occurs (Anton et al. 1994). Using appropriate hydrogels to replicate the in vivo 
environment, this device could be used to determine if this is factual. 
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Chapter 8 Conclusions and Recommendations  
8.1 Conclusions 
 
Our device has been successful in the formation of multiple hydrogel layers 
seeded with various cell types. These gels are capable of observation under a microscope 
to allow for the analysis of cellular behavior and interactions. This device also 
demonstrated that it was possible for the cells to move from layer to layer.  
 Although vascularization of TIME cells was not observed throughout the project, 
it can be concluded that the device could allow for this to occur. Since the cells are able 
to migrate between layers, proliferate, interact with each other, and respond to gradients, 
given enough time, we expect the endothelial cells to differentiate into capillaries that 
mimic neovascularization in tumors. We did not experience this in our study due to the 
constraints of cell culture and cell behavior. In an ideal situation, this should be more 
easily achieved and observed.  
 This device provides a more reliable drug-testing platform than current methods. 
It also provides a scalable and reproducible process to create cultures for drug testing and 
analysis. Lastly, this device has multiple applications in the field of biomedical 
engineering and cell culture. It cannot only potentially be used for angiogenesis assays, 
but also to observe cell migration, cell-cell interactions, and create accurate 
microenvironments of various cell types in harmony.  
8.2 Recommendations 
 
 After the completion of this project the team has several recommendations for the 
future of this device. Due to numerous limitations, including both time and resources, 
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there are a few different goals that the team could not fully complete. The 
recommendations include improving the design of the device, using different hydrogels 
that more accurately represent the in vivo environment of a tumor, and to use the device 
to test anti-angiogenic drugs. 
8.2.1 Improved Design 
 
 Although the design of the device works sufficiently to complete the intended 
purpose, there are a few different improvements that could be made to increase its 
effectiveness. The alteration that should be implemented first is to try and redesign the 
device so that the middle layer is crosslinked prior to the two outside layers. The purpose 
for this change is to greatly reduce the possibility of cell leakage between the layers. 
Although cell leakage during seeding is not a frequent occurrence while using the current 
device, it does happen often enough to pose a problem. By crosslinking the middle layer 
first and allowing it to completely form prior to forming the two outside layers that 
contain the cells, this issue should be resolved.  
 A major flaw with the device in its current stage is the material. It is a special type 
of plastic used for rapid prototyping. Its properties are not ideal for 3D culture because it 
lacks hydrophobicity, which is required to maximize the efficiency of creating layers. A 
material that is biocompatible and hydrophobic should be used to manufacture the device. 
An alternative to material choice would be polystyrene, which is used for current tissue 
culture plates and dishes. This material has already been tested for use in cell culture and 
various assays. By remodeling the design, the step of creating a PDMS disc could be 
removed. Instead, a 3D tissue culture well could be designed to the shape and dimensions 
of the PDMS disc and act as a tissue culture dish with a channel for multi-layer 3D cell 
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culture. This would improve the device’s biocompatibility. It would also make the device 
disposable to make it more marketable. Using tissue-culture polystyrene would be 
cheaper than using the current material. The divider component of the device should also 
be manufactured with a more hydrophobic material.  
 Another option is to 3D print the device using a metal or metal alloy. Combined 
with a hydrophobic coating, the device could withstand multiple sterilization cycles and 
multiple uses.  
In addition to the six-well plate design, the design could be modified to be 
adaptable to other well plates. If a design is created for a 24-well plate, then many 
cultures could be observed simultaneously. This design would increase the 
reproducibility of results when performing a variety of assays. It could then be modified 
for 96-well plates as well. Automation could be applied to the larger well-plate numbers 
to increase the high-throughput potential of the device. This would also remove the 
chances of human error; potentially increasing the accuracy of the any assays performed 
using the device.  
8.2.2 Gel Selection 
 
 For the purpose of this project, RGD coupled alginate was used as the hydrogel. 
The reasoning for the choice was because of its immediate gelation time, good cell 
attachment, and ease of use. Due to these factors it was an optimal gel for experiments, 
but not the best choice for replicating the in vivo environment of a tumor. The team 
recommends that other hydrogels be considered to better represent the microenvironment. 
Human organs are comprised of multiple tissues with varying properties. Using the 
device, the team only used one hydrogel to create a multi-layer 3D culture. To ensure 
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more accurate studies, multiple hydrogels should be used to represent the in vivo 
environment. Extracellular matrix proteins are found in abundance in human tissues. 
Hydrogels that the team used are alginate, gelatin, and a synthesized-peptide hydrogel 
similar to PuraMatrix. Alginate is not found in the human body and thus does not 
represent human physiology. For testing the design, gelatin did not crosslink fast enough 
although it is derived from collagen and more representative of human tissue. The peptide 
hydrogel was difficult to work with because of its pH. When studying cells, especially 
cancer cells, or performing assays to study realistic cellular processes, hydrogels that are 
composed of ECM proteins should be used. Examples include any ECM-based hydrogels 
containing laminin, collagen, elastin, or fibronectin.  
8.2.3 Anti-angiogenic Drug Testing 
 
 Due to time constraints the team was not able to test the devices capabilities as a 
drug-testing platform. Once angiogenesis is achieved, the next step recommended by the 
team would be to add anti-angiogenic drugs into the channel to try and prevent 
angiogenesis. The purpose of this experiment would be to verify that this device could be 
used as a drug-testing platform, which is one of its intended purposes. 
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A7003 SIGMA Alginic acid from brown algae. (2016). Retrieved from 
http://www.sigmaaldrich.com/catalog/product/sigma/a7003?lang=en&region=US 
 
ATCC®. MDA-MB-231 ATCC ® HTB-26™ Homo Sapiens Mammary Gland/breast. 
 
ATCC®. TIME (ATCC® CRL-4025™) Homo Sapiens Foreskin. ATCC (2014). 
Retrieved from http://www.atcc.org/products/all/CRL-4025.aspx 
 
BD PuraMatrix Peptide Hydrogel. (2004).   Retrieved from 
http://puramatrix.com/protocol_pdfs/PuraMatrix_Guidelines.pdf 
 
Corning® 384 Well Black Clear Round Bottom Ultra-Low Attachment Spheroid 
Microplate, Bulk Packed 10 per Bag, with Lid, Sterile (Product #3830). (2015).   
Retrieved from http://catalog2.corning.com/LifeSciences/en-
US/Shopping/ProductDetails.aspx?categoryname=&productid=3830(Lifesciences) 
  
Corning® 96 Well Clear Black Round Bottom Ultra Low Attachment Spheroid 
Microplate, Bulk Packed, with Lid, Sterile, 10/Bag (Product #4520). (2015).   Retrieved 
from http://catalog2.corning.com/LifeSciences/en-
US/Shopping/ProductDetails.aspx?categoryname=&productid=4520(Lifesciences) 
  
Corning Matrigel Matrix. (2013). Retrieved from 
https://www.corning.com/media/worldwide/cls/documents/CLS-DL-CC-026%20DL.pdf 
 
Corning® PuraMatrix™ Peptide Hydrogel, 5mL (Product #354250). (2015).   Retrieved 
from http://catalog2.corning.com/Lifesciences/en-
US/Shopping/ProductDetails.aspx?productid=354250(Lifesciences)&categoryname= 
 
Corning® Spheroid Microplates User Guide. (2014): Corning Incorporated. Retrieved 
from 
http://csmedia2.corning.com/LifeSciences/media/pdf/Instruction_for_Use_CLS_AN_235
_Corning_Spheroid_Plates.pdf  
 
G1393 Sigma Gelatin Solution. (2016). Retrieved from 
http://www.sigmaaldrich.com/catalog/product/sigma/g1393?lang=en&region=US 
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Appendix B:RGD Conjugation Standard Operating Procedure 
Title: RGD Coupled Alginate Conjugation 
 
1.0 Purpose 
To describe the procedure for conjugating the GRGDSP peptide to alginate to acquire 
cell attachment properties within the gel. This procedure creates approximately 0.16g 
of GRGDSP coupled alginate and can be modified to create desired amounts.  
 
2.0 Scope 
This procedure applies to conjugating any RGD peptide to alginate for cell 
attachment.  
 
3.0 Responsibility 
All personnel working in research facilities at Worcester Polytechnic Institute. 
 
4.0 Definitions 
 
EDC - 1-ethyl-3-(dimethylaminopropyl)carbodiimide 
 
GRGDSP - Gly-Arg-Gly-Asp-Ser-Pro 
 
MES - 2-(N-morpholino)ethanesulfonic acid 
 
NaCl – Sodium Chloride 
 
Sulfo-NHS – N-hydroxysulfosuccinimide 
 
 
5.0 Materials 
Alginic acid sodium salt from brown algae (Sigma Aldrich, Cat # A1112) 
 
EDC (Sigma Aldrich, Cat # 03450) 
 
GRGDSP (Anaspec, Cat #AS-22946) 
 
MES (Sigma Aldrich, Cat # M3671) 
 
NaCl (Amresco, Cat # 7647-14-5) 
 
Por 7 Pre-wetted Dialysis Trial Kit (Spectrum Labs, Cat # 132112T) 
 
Stir plate and stir bars 
 
Sulfo- NHS (CovaChem, Cat # 13505-500) 
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6.0 Procedure 
 
1. Prepare MES stock solution (0.5M):  
a. Add 9.76g MES buffer powder to about 60 ml of distilled water. 
b. Place on stir plate and stir until dissolved. 
c. Use pH meter and bring pH to 6.5. 
d. Add distilled water to bring total volume to 100 ml. 
e. Use pH meter and bring pH back to 6.5. 
2. Prepare NaCl stock solution (3M): 
a. Add 43.83 g NaCl powder to about 150 ml water. 
b. Mix on stir plate until dissolved. 
c. Remove stir bar and add distilled water bring total volume to 250 ml. 
3. Prepare 3% w/v alginate stock solution by dissolving 1.5 g alginic acid sodium 
salt into 50 ml distilled water.  
4. Mix 6 ml of MES buffer solution with 3 ml of NaCl solution and add 10 ml of 3% 
w/v alginate. 
5. Add 150 µl EDC stock to solution. 
6. Add 84 µl sulfo-NHS stock to solution (add between 50-200 microliters of NHS 
and EDC to minimize error). 
7. Stir solution for 15 minutes to activate the carboxylic acid groups. 
8. Add 60 µl GRGDSP peptide to the complete solution. 
9. Add distilled water to bring total volume to 30 ml and stir for 24 hours at ambient 
temperature to allow conjugation reaction to occur. 
10. Place entire solution in dialysis tubing (MWCO 3500 Da) and clamp both ends. 
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11. Place tubing in a 4L autoclaved beaker and gently stir for 3 days. 
12. Change dialysis water twice in the first 24 hours and then once every 24 hours. 
13. Lyophilize solution to a powder (~ 0.16g) 
14. Reconstitute to a concentration of 3% w/v using Ca++/Mg++ free DPBS. 
 
 
7.0 Attachments 
 
Solution Stock 
Concentration 
Final 
Concentration 
Volume Used Source & Cat. 
# 
Alginate 3% w/v 1% 10 ml Sigma Aldrich 
Cat. # A1112 
MES 0.5 M 0.1 M 6 ml Sigma Aldrich, 
Cat. # M3671 
NaCl 3 M 0.3 M 3 ml Amresco, Cat. # 
7647-14-5 
Sulfo-NHS 100 mg/ml 28 mg/g alginate 84 µl CovaChem, Cat. 
# 13505-500 
EDC 100 mg/ml 50 mg/g alginate 150 µl Sigma Aldrich, 
Cat. # 03450 
GRGDSP 5 mg/ml 1 mg/g alginate 60 µl Anaspec, Cat. 
#AS-22946 
Stock solution table for procedure 
 
 
 
 
Chemical structure of GRGDSP coupled alginate (Andersen, Auk-Emblem et al. 2015) 
 
 
 
8.0 References 
Andersen, T., Auk-Emblem, P., & Dornish, M. (2015). 3D Cell Culture in Alginate 
Hydrogels. Microarrays, 4(2), 133-161.  				
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Appendix C: Device Standard Operating Procedure 
Title: Coculture Assay using PDMS channel 
1.0 Purpose 
To describe the procedure for assaying the interactions between two cell types in a 
PDMS channel. 
 
2.0 Scope 
This procedure applies to any cell types. 
 
3.0 Responsibility 
All personnel working in research facilities at Worcester Polytechnic Institute. 
 
4.0 Definitions 
 
PDMS - Polydimethysiloxane 
 
RGD - Arginylglycylaspartic acid 
 
CaCl2 - Calcium chloride  
 
DPBS - Dulbecco's phosphate-buffered saline 
 
5.0 Materials 
 
Sylgard Silicone Elastomer base (Ellsworth Adhesive #184 SYL ELAST) 
 
Sylgard Silicone Elastomer curing agent (Ellsworth Adhesive #184 SYL ELAST) 
 
RGD Alginate- Conjugated using Alginic Acid (Sigma Aldrich, Cat # A1112) and 
GRGDSP (Anaspec, Cat #AS-22946) according to a prior SOP 
 
DPBS(-) (Cat # 21-031-CV, Corning)  
 
Cells being analyzed 
 
Culture Medium appropriate for cells being analyzed 
 
6.0 Procedure 
1. Weigh 10 parts Sylgard Silicone Elastomer base. 
2. Separately weigh 1 part of Sylgard Silicone Elastomer curing agent. 
3. Thoroughly mix the reagents and pour into device, filling to the top of the mold                                                                                                               
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4. Place device in vacuum chamber to degas for at least an hour until all air bubbles 
are eliminated. 
5. Place in oven at 60oC to cure for at least an hour until the PDMS is no longer 
tacky to the touch.  
6. Remove PDMS from device carefully using forceps. 
7. Sterilize PDMS channel by autoclaving for 20 minutes prior to experimentation 
with cells. 
8. Prepare cells being analyzed. 
a. Trypsinize cells and transfer to centrifuge tube. 
b. Obtain cell count and resuspend at 500,000 cells/mL. 
c. Transfer 1 mL of each cell suspension to eppendorf tube. 
d. Centrifuge cells at 200G for 5 minutes. 
e. Aspirate the media using a pipet tip, being careful not to aspirate the cell 
pellet. 
f. Resuspend cell pellet in 100µL RGD alginate. 
9. Place PDMS mold into large culture dish and insert the divider piece into their 
respective slots. 
10. Carefully pipet 10µL (50,000 cells) of the first cell-RGD alginate mixture into 
layer one, taking caution to ensure the gel reaches the bottom of the layer. 
11. Repeat Step 10 for second cell type into layer three. 
12. Pipet 35µL of CaCl2 onto each gel layer and allow to crosslink for 10 minutes. 
13. Aspirate CaCl2 using pipet, taking caution not to disrupt the gel. 
14. Remove divider piece. 
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15. Carefully pipet 10µL of RGD alginate with no cells into layer two, taking to 
ensure the gel reaches the bottom of the layer. 
16. Pipet 35µL of CaCl2 onto layer two and allow to crosslink for 10 minutes. 
17. Aspirate CaCl2 using pipet, taking caution not to disrupt the gel. 
18. Place 35µL of the media for each cell type on the opposite side of their respective 
layers to induce migration and interaction. 
19. Flood the culture dish with DPBS(-) to avoid evaporation, taking caution not to let 
the DPBS(-) level rise above the PDMS channel. 
20. Incubate culture at 37oC and 5% CO2, changing media in channel daily. 
 
 
